日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer

撤稿声明:在人类前列腺癌中鉴定出一种新型的microRNA-mRNA调控生物模块

Zhang, Yanqiong; Jiang, Funeng; He, Huichan; Ye, Jianheng; Mao, Xia; Guo, Qiuyan; Wu, Shu-Lin; Zhong, Weide; Wu, Chin-Lee; Lin, Na

Prostate Cancer Risk and DNA Mismatch Repair Deficiency Among Lynch Syndrome Patients

林奇综合征患者的前列腺癌风险与DNA错配修复缺陷

Rodgers-Fouché, Linda; Kamkari, Nick A; Cruz, Melany; Gusev, Andrew; Justiniano, Sara I; Wu, Chin-Lee; Chung, Daniel C; Salari, Keyan

The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate

泌尿生殖病理学会和国际泌尿病理学会关于前列腺导管内癌的联合专家咨询建议

Shah, Rajal B; Varma, Murali; Zhou, Ming; Paner, Gladell P; Amin, Mahul B; Berney, Daniel M; Cheng, Liang; Deng, Fang-Ming; Downes, Michelle; Eggener, Scott; Ehdaie, Behfar; Epstein, Jonathan I; Evans, Andrew; Fine, Samson W; Greenland, Nancy; Guo, Charles; Han, Bo; Hirsch, Michelle S; Izkowski, Kenneth A; Kench, James G; Lotan, Tamara L; Magi-Galluzzi, Cristina; Miyamoto, Hiroshi; Nguyen, Jane K; Tsuzuki, Toyonori; van der Kwast, Theodorus H; van Leenders, Geert J; Williamson, Sean R; Wobker, Sara E; Wu, Chin-Lee; Yang, Ximing; Kristiansen, Glen

Androgen receptor splice variant expression and prostate cancer recurrence after salvage therapy

雄激素受体剪接变体表达与挽救治疗后前列腺癌复发

Konieczkowski, David J; Otani, Keisuke; Guan, Zoe; Drumm, Michael R; Otani, Yukako; Badusi, Priscilla Oluwakemi; Chung, Ella H; Wu, Shulin; Davicioni, Elai; Saylor, Philip J; Wu, Chin-Lee; Efstathiou, Jason A; Miyamoto, David T

Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial

肌层浸润性膀胱癌患者接受每日两次放疗联合 5-氟尿嘧啶/顺铂或每日一次放疗联合吉西他滨治疗以保留膀胱的长期疗效——NRG/RTOG 0712 最新报告:一项随机 II 期试验

Coen, John J; Rodgers, Joseph P; Saylor, Philip J; Lee, Cheryl T; Wu, Chin-Lee; Parker, William; Lautenschlaeger, Tim; Zietman, Anthony L; Efstathiou, Jason; Jani, Ashesh B; Kucuk, Omer; Souhami, Luis; Pugh, Stephanie L; Sandler, Howard M; Shipley, William U

Single-Cell and Spatial Transcriptomics Reveal a Tumor-Associated Macrophage Subpopulation that Mediates Prostate Cancer Progression and Metastasis

单细胞和空间转录组学揭示了一种肿瘤相关巨噬细胞亚群,该亚群介导前列腺癌的进展和转移

Shenglin Mei # ,Hanyu Zhang # ,Taghreed Hirz ,Nathan Elias Jeffries ,Yanxin Xu ,Ninib Baryawno ,Shulin Wu ,Chin-Lee Wu ,Akash Patnaik # ,Philip J Saylor # ,David B Sykes # ,Douglas M Dahl #

Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate Cancer

免疫空间组织可预测侵袭性局限性前列腺癌的转移风险

Yang, David D; Abdelnaser, Aya; Wala, Jeremiah; Haas, Alexander J; Barney, Alfred A; Saad, Eddy; Crowdis, Jett P; Ricker, Cora A; Park, Jihye; King, Martin T; Nguyen, Paul L; Choueiri, Toni K; Tewari, Alok K; Salari, Keyan; Taplin, Mary-Ellen; Wu, Chin-Lee; Van Allen, Eliezer M

Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926

保留膀胱的三联疗法治疗高级别T1期膀胱癌:NRG Oncology/RTOG 0926 II期方案的结果

Dahl, Douglas M; Rodgers, Joseph P; Shipley, William U; Michaelson, M Dror; Wu, Chin-Lee; Parker, William; Jani, Ashesh B; Cury, Fabio L; Hudes, Richard S; Michalski, Jeff M; Hartford, Alan C; Song, Daniel; Citrin, Deborah E; Karrison, Theodore G; Sandler, Howard M; Feng, Felix Y; Efstathiou, Jason A

Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.

透明细胞肾细胞癌原发肿瘤和骨转移病灶中免疫细胞和基质细胞重塑的单细胞分析

Mei Shenglin, Alchahin Adele M, Tsea Ioanna, Kfoury Youmna, Hirz Taghreed, Jeffries Nathan Elias, Zhao Ting, Xu Yanxin, Zhang Hanyu, Sarkar Hirak, Wu Shulin, Subtelny Alexander O, Johnsen John Inge, Zhang Yida, Salari Keyan, Wu Chin-Lee, Randolph Mark A, Scadden David T, Dahl Douglas M, Shin John, Kharchenko Peter V, Saylor Philip J, Sykes David B, Baryawno Ninib

Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation

不接受膀胱切除术的肌层浸润性膀胱癌患者接受放化疗的长期疗效。NRG Oncology RTOG 0524-A 1/2期临床试验的最终结果:紫杉醇联合曲妥珠单抗每日放疗或单用紫杉醇每日放疗。

Dahl, Douglas M; Karrison, Theodore G; Michaelson, M Dror; Pham, Huong T; Wu, Chin-Lee; Swanson, Gregory P; Shipley, William U; Vuky, Jacqueline; Lee, R Jeffrey; Zietman, Anthony L; Souhami, Luis; Chang, Brian K; Deming, Richard L; Ellerton, John A; Sandler, Howard M; Rodgers, Joseph P; Feng, Felix Y; Efstathiou, Jason A